Armistice Capital, LLC Grifols Sa Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in Grifols Sa stock. As of the latest transaction made, Armistice Capital, LLC holds 6,648,000 shares of GRFS stock, worth $41.9 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
6,648,000Holding current value
$41.9 Million% of portfolio
0.6%Shares
1 transactions
Others Institutions Holding GRFS
# of Institutions
150Shares Held
140MCall Options Held
3.54MPut Options Held
919K-
Capital World Investors Los Angeles, CA20.7MShares$131 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA17.1MShares$108 Million1.53% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$90.4 Million0.04% of portfolio
-
Permian Investment Partners, LP New York, NY12.8MShares$80.9 Million11.07% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.5MShares$72.2 Million2.32% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.28B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...